Serum Indices External Quality Assessment
Serum Indices External Quality Assessment
The RIQAS Serum Indices EQA programme is designed for the pre-analytical assessment of Haemolytic, Icteric and Lipemic (HIL) interferences.
Available in a bi-monthly format with the option to report either quantitative or semi-quantitative results for the HIL parameters, this programme also provides an assessment on how these interferences impact on up to 25 routine chemistry parameters. This provides invaluable information on whether a correct judgement is being made to report results.
- Lyophilised for enhanced stability
- Human based serum ensuring commutable sample matrix
- Bi-monthly reporting
- HIL parameters include the option of quantitative or semi-quantitative reporting
- Interpretation of chemistry parameter results
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
NOTE: If you require additional Serum Indices EQA material, you can purchase RQ9194/A. This is an additional pack containing 9 x 1ml vials to be used as a supplement to your main RQ9194 Serum Indices programme.
| Cat No | Kit Size | Frequency | Cycle Start | Returns | |
|---|---|---|---|---|---|
| RQ9194 | 2 x (9 x1ml) | Bi-monthly (9 samples per distribution), 2 distributions per cycle | September | 3 samples bi-monthly | |
Indices Assessment (Quantitative and Semi-Quantitative)
- Haemolysis
- Icteric
- Lipemic
Parameter Assessment (Quantitative)
- ALP
- ALT
- AST
- D. Bilirubin
- T. Bilirubin
- Calcium
- Chloride
- Cholesterol
- CK NAC
- Creatinine
- GGT
- Glucose
- HDL
- Iron
- Lactate
- Ldh
- Lipase
- Magnesium
- Phosphate
- Potassium
- Protein Total
- Sodium
- Triglycerides
- Urea
- Uric Acid
Related Products
Coagulation External Quality Assessment
The RIQAS Coagulation EQA programme is designed to monitor the performance of 17 routine coagulation tests and specialised factor assays. Two flexible yet cost effective programme options are available.
- Accredited to ISO/IEC 17043:2010
- Lyophilised for enhanced stability
- 100% human plasma
- Monthly reporting
- Choose between 5 routine parameters or all 17 parameters
- Submit results and view reports online via RIQASNet
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9135/a | 12 x 1ml | Monthly (1 x 12 month cycle) | January | 5 selected parameters (aPTT, PT, TT, Fibrinogen and ATIII) | |
| RQ9135/b | 12 x 1ml | Monthly (1 x 12 month cycle) | January | All 17 parameters | |
Routine Parameters
- Activated Partial Thromboplastin Time (aPTT)
-
Antithrombin III (ATIII)
- Fibrinogen
- Prothrombin Time (PT)
- Thrombin Time (TT)
Parameters
- Activated Partial Thromboplastin Time (aPTT)
- Antithrombin III (ATIII)
- D-Dimer (Pilot)
- Factor II
- Factor IX
- Factor V
- Factor VII
- Factor VIII
- Factor X
- Factor XI
- Factor XII
- Fibrinogen
- Plasminogen
- Protein C
- Protein S
- Prothrombin Time (PT)
- Thrombin Time (TT)
Please note, product availability may vary country to country.
Related Products
Therapeutic Drugs External Quality Assessment
The RIQAS Therapeutic Drug EQA programme is designed to monitor the performance of an impressive 18 therapeutic drugs. Weighed in values are reported for each parameter.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Weighed in values reported for each parameter
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9111 | 12 x 5ml | Bi-weekly (2 x 6 monthly cycles) | March / Sept | 18 | |
| MS5007 | 20 x 5ml | N/A | N/A | N/A | |
Parameters
- Amikacin
- Caffeine
- Carbamazepine
- Cyclosporine
- Digoxin
- Ethosuximide
- Gentamicin
- Lithium
- Methotrexate
- Paracetamol
- Phenobarbital
- Phenytoin
- Primidone
- Salicylic Acid
- Theophylline
- Tobramycin
- Valproic Acid
- Vancomycin
Please note, product availability may vary country to country.
Related Products
Specific Protein External Quality Assessment
The RIQAS Specific Protein EQA programme is designed to monitor the performance of up to 26 serum proteins including CRP, ASO, RF, Complement Proteins and Immunoglobulins. Four programme options are available to help reduce waste and costs.
- Accredited to ISO/IEC 17043
- Liquid ready-to-use
- 100% human serum
- Flexible options available with bi-weekly or monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9114 | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | March / Sept | 26 analytes | |
| RQ9187 | 12 x 1ml | Monthly | March | 26 analytes | |
Parameters
- AFP
- Albumin
- Alpha-1-acid glycoprotein
- Alpha-1-antitrypsin
- Alpha-2-macroglobulin
- Anti Streptolysin O
- Antithrombin III
- Beta-2-microglobulin
- Ceruloplasmin
- Complement, C3
- Complement, C4
- C-Reactive Protein
- Ferritin
- Haptoglobin
- Immunoglobulin A
- Immunoglobulin E
- Immunoglobulin G
- Immunoglobulin M
- Free Kappa Light Chain
- Total Kappa Light Chain
- Free Lambda Light Chain
- Total Lambda Light Chain
- Prealbumin (Transthyretin)
- Retinol Binding Protein
- Rheumatoid Factor
- Transferrin
Please note, product availability may vary country to country.
Related Products
Maternal Screening External Quality Assessment
The RIQAS Maternal Screening EQA programme is designed to monitor the performance of screening tests used during the first and second trimester of pregnancy to assess the risk of Down’s syndrome, Spina Bifida and Trisomy 18.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Suitable for first and second trimester screening
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9137 | 12 x 1ml | Monthly (1 x 12 month cycle) | January | 6 | |
Parameters
- AFP
- Inhibin A
- hCG, free beta
- PAPP-A
- hCG, total
- Unconjugated Oestriol
Please note, product availability may vary country to country.
Related Products
Cardiac Plus External Quality Assessment
The RIQAS Cardiac Plus EQA programme is designed to monitor the performance of 11 clinically significant cardiac markers. All samples are supplied in a lyophilised format.
- Accredited to ISO/IEC 17043
- Lyophilised
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments at no extra cost
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9190 | 12 x 3ml | Monthly (1 x 12 month cycle) | January | 11 parameters | |
Parameters
- CK Total
- CK-MB Activity
- CK-MB Mass
- D-Dimer
- Digoxin
- Homocysteine
- hsCRP
- Myoglobin
- NT-proBNP
- Troponin I
- Troponin T
Please note, product availability may vary country to country.
Lipids External Quality Assessment
The RIQAS Lipid EQA programme is designed to monitor the performance of up to 8 lipid parameters. Two flexible and cost effective programme options are available.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Choose from 3 or all 8 parameter options
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9126/a | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | January/July | 3 parameters (choose from 8) | |
| RQ9126/b | 12 x 3ml | Bi-weekly (2 x 6 monthly cycles) | January/July | All 8 parameters | |
Parameters
- Apolipoprotein A1
- LDL-Cholesterol
- Triglycerides
- Apolipoprotein B
- Lipoprotein (a)
- Non-HDL Cholesterol*
- HDL-Cholesterol
- Total Cholesterol
Please note, product availability may vary country to country.
*Pilot programmes.
Related Products
Immunoassay Speciality 2 External Quality Assessment
The RIQAS Immunoassay Speciality 2 EQA programme is designed to monitor the performance of 5 complex, specialised immunoassay parameters.
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9142 | 12 x 1ml | Monthly Reporting | Jan | 5 | |
Parameters
- Calcitonin
- Gastrin
- Procalcitonin
- Plasma Renin Activity
- Renin, direct concentration
Please note, product availability may vary country to country.
Related Products
Immunoassay Speciality I External Quality Assessment
The RIQAS Immunoassay Speciality I EQA programme is designed to monitor the performance of 10 complex, specialised immunoassay parameters including procalcitonin and vitamin D.
- Lyophilised for enhanced stability
- 100% human serum
- Monthly reporting
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
- Accredited to ISO/IEC 17043
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9141 | 12 x 2ml | Monthly Reporting | Jan | 10 | |
Parameters
- 1-25-OH-Vitamin D*
- 25-OH-Vitamin D
- Anti-TG
- Anti-TPO
- C-peptide
- IGF-1
- Insulin
- Osteocalcin
- Procalcitonin
- PTH
*Pilot Programme
Please note, product availability may vary country to country.
Related Products
Immunoassay External Quality Assessment
The RIQAS Immunoassay EQA programme is designed to monitor the performance of up to 51 immunoassay parameters including therapeutic drugs; hormones and tumour markers. Four flexible and cost effective programme options are available.
- Accredited to ISO/IEC 17043
- Lyophilised for enhanced stability
- 100% human serum
- Bi-weekly reporting
- Choose 4 parameters, 13 parameters or all 51 parameters
- Submit results and view reports online via RIQAS.Net
- Register up to five instruments per programme (volume permitting) at no extra cost for comparative performance assessment
| Cat No | Kit Size | Frequency | Cycle Start | Parameters | |
|---|---|---|---|---|---|
| RQ9125/a | 12 x 5ml | Bi-weekly programmes | Jan / July | 4 parameters only (Choose from 51) | |
| RQ9125/b | 12 x 5ml | Bi-weekly programmes | Jan / July | 13 parameters only (Choose from 51) | |
| RQ9125/c | 12 x 5ml | Bi-weekly programmes | Jan / July | All 51 parameters (Bi-weekly reporting) | |
| RQ9130 | 12 x 5ml | Monthly Programmes | Jan | All 51 parameters (Monthly reporting) | |
| MS5007 | 20 x 5ml | N/A | N/A | N/A | |
Parameters
- 1-25-OH-Vitamin D (Pilot)
- 17-OH-progesterone
- 25-OH-Vitamin D
- ACTH
- AFP
- Aldosterone
- Amikacin
- Androstenedione
- B-2-Microglobulin
- CA125
- CA15-3
- CA19-9
- Carbamazepine
- CEA
- Cortisol
- C-peptide
- DHEA, Unconjugated
- DHEA-S
- Digoxin
- Ferritin
- Folate
- Free T3
- Free T4
- Free testosterone (Pilot)
- FSH
- Gentamicin
- GH
- hCG
- IgE
- Insulin
- LH
- Oestradiol
- Paracetamol
- Parathyroid Hormone
- Phenobarbital
- Phenytoin
- Progesterone
- Prolactin
- PSA
- PSA, Free
- Salicylate
- Sex Hormone Binding Globulin (SHBG)
- T3
- T4
- Testosterone
- Theophylline
- Thyroglobulin
- TSH
- Valproic acid
- Vancomycin
- Vitamin B12
Please note, product availability may vary country to country.